英文别名:
ACP-5862;BDBM474105;US10858364, formula (I);CC#CC(=O)NCCCC(=O)C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=NC=CC=C1;4-[8-Amino-3-[4-(but-2-ynoylamino)butanoyl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide;Acalabrutinib Metabolite 27(Acalabrutinib Impurity 1);AKOS040732378;GLXC-26720;4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-benzamide;G17359;MS-28950;HY-135334;CS-0111509;Acalabrutinib Metabolite 27 (Acalabrutinib Impurity 1);2230757-47-6;SCHEMBL20327799;ARD181905;DA-50180;
Inchi:
1S/C26H23N7O3/c1-2-6-21(35)29-14-5-7-19(34)25-32-22(23-24(27)30-15-16-33(23)25)17-9-11-18(12-10-17)26(36)31-20-8-3-4-13-28-20/h3-4,8-13,15-16H,5,7,14H2,1H3,(H2,27,30)(H,29,35)(H,28,31,36)